Engineered Migrasomes: Harnessing Core Migrasome Machinery and Hypotonic Shock to Develop a Robust and Thermally Stable Vaccine Platform

This article has 7 evaluations Published on
Read the full article Related papers
This article on Sciety

Abstract

The increasing ability of pathogens and tumor cells to evade immune detection underscores the urgent need for novel vaccine platforms leveraging diverse biological mechanisms. Additionally, logistical challenges associated with cold-chain transportation significantly limit vaccine accessibility, especially in resource-limited regions. Recently, we identified migrasomes, specialized organelles generated during cell migration, which are inherently stable and enriched with immune-modulating molecules. To address the low yield of natural migrasomes, we engineered migrasome-like vesicles (eMigrasomes) using hypotonic shock combined with cytoskeletal disruption to enhance vesicle formation. The biogenesis of eMigrasomes relies on the core migrasome machinery, faithfully recapitulating the biophysical attributes of native migrasomes while significantly improving production efficiency. We demonstrate that eMigrasomes loaded with a model antigen elicit potent antibody responses and maintain structural integrity and immunogenic potential at room temperature. Furthermore, eMigrasomes displaying the SARS-CoV-2 Spike protein induce robust humoral immune responses, providing effective protection against viral infection. Our findings highlight the potential of utilizing migrasome biology and hypotonic shock-driven vesicle generation as an innovative, stable, and broadly accessible vaccine platform.

Related articles

Related articles are currently not available for this article.